alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JAN-04-1998
<PERIOD-START>                             DEC-30-1996
<PERIOD-END>                               OCT-05-1997
<CASH>                                          19,347
<SECURITIES>                                         0
<RECEIVABLES>                                   88,794
<ALLOWANCES>                                     3,450
<INVENTORY>                                    135,887
<CURRENT-ASSETS>                               253,985
<PP&E>                                         277,719
<DEPRECIATION>                                  89,830
<TOTAL-ASSETS>                                 490,685
<CURRENT-LIABILITIES>                          167,068
<BONDS>                                         89,558
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           222
<OTHER-SE>                                     209,466
<TOTAL-LIABILITY-AND-EQUITY>                   409,685
<SALES>                                      1,084,454
<TOTAL-REVENUES>                             1,084,454
<CGS>                                          928,883
<TOTAL-COSTS>                                  928,883
<OTHER-EXPENSES>                               119,750
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               5,877
<INCOME-PRETAX>                                 30,168
<INCOME-TAX>                                    11,505
<INCOME-CONTINUING>                             18,663
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    18,663
<EPS-PRIMARY>                                     0.82
<EPS-DILUTED>                                     0.81
        

</TABLE>
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

ORDER FOR DISMISSAL

CARTER/CR06-89RSL - 1

UNITED STATES ATTORNEY

700 Stewart Street, Suite 5220

Seattle, Washington 98101-1271

(206) 553-7970

The Honorable Robert S. Lasnik

UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF WASHINGTON

AT SEATTLE 

UNITED STATES OF AMERICA, )) NO. CR06-89RSL Plaintiff, ) v. )) ORDER TO DISMISS LAWRENCE CARTER, ) INDICTMENT WITHOUT ) PREJUDICE Defendant ) ______________________________)

This matter having come on before the undersigned court on the Government’s

Motion to Dismiss without Prejudice, pursuant to F.R.Cr.P. 48, the Court having

considered the Motion and files and records, now therefore,

DISMISSES WITHOUT PREJUDICE the above-entitled Indictment as the

conduct charged is subsumed into United States v. Kavel Multani, et al., CR06-38RSM. 

DATED the 17th day of May, 2006. 

A

Robert S. Lasnik

United States District Judge

Case 2:06-cr-00089-RSL Document 12 Filed 05/17/06 Page 1 of 1
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

ORDER GRANTING STIPULATED MOTION

TO CONTINUE TRIAL DATE AND 

PRETRIAL MOTIONS’ DEADLINE 1 

FEDERAL PUBLIC DEFENDER

1331 Broadway, Ste. 400

Tacoma, Washington 98402

(253) 593-6710

JUDGE FRANKLIN D. BURGESS

UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF WASHINGTON

AT TACOMA

UNITED STATES OF AMERICA,

Plaintiff,

vs.

EDWARD FERGUSON,

Defendant.

 

)

)

)

)

)

)

)

)

)

)

)

NO. CR06-5040FDB 

ORDER GRANTING STIPULATED

MOTION TO CONTINUE TRIAL

DATE AND PRETRIAL MOTIONS’

DEADLINE

Upon the stipulation of the parties to continue the trial date in the abovecaptioned case, and the Defendant’s Waiver of Speedy Trial Rights, the Court finds that

a failure to grant the continuance would deny counsel the reasonable time necessary for

effective preparation, taking into account the exercise of due diligence, within the

meaning of 18 U.S.C. § 3161(h)(8)(B)(ii). 

The Court further finds that the ends of justice will be served by ordering a

continuance n this case, that a continuance is necessary to insure effective trial

preparation and that these factors outweigh the best interests of the public and the

defendant in a speedy trial; therefore, 

IT IS HEREBY ORDERED that the trial in this matter be continued to June 26,

2006, at 9:00 a.m. with a pretrial motions’ deadline of March 31, 2006, and a Pretrial

Case 3:06-cr-05040-RBL Document 24 Filed 03/08/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

ORDER GRANTING STIPULATED MOTION

TO CONTINUE TRIAL DATE AND 

PRETRIAL MOTIONS’ DEADLINE 2 

FEDERAL PUBLIC DEFENDER

1331 Broadway, Ste. 400

Tacoma, Washington 98402

(253) 593-6710

Conference scheduled for June 16, 2006.

 The period of delay resulting from this continuance of the trial date from March

27, 2006, up to and including the new trial date of June 26, 2006 is hereby excluded for

speedy trial purposes under 18 U.S.C. §3161(h)(8)(A) and (B).

DONE this 8th day of March, 2006. 

A

FRANKLIN D. BURGESS

UNITED STATES DISTRICT JUDGE

Presented by:

 /s/ 

MIRIAM F. SCHWARTZ

Attorney for Defendant

 /s/ 

KENT Y. LIU

Assistant United States Attorney

Case 3:06-cr-05040-RBL Document 24 Filed 03/08/06 Page 2 of 2
Exhibit 32



SECTION 1350 CERTIFICATION



The undersigned certify that:



(1)        The accompanying Quarterly Report on Form 10-Q/A for the period ended September 30, 2007, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)        The information contained in the accompanying Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:   March 7, 2008
        /s/  Scott F. DrillScott F. DrillPresident and Chief Executive Officer(principal executive officer)Date:   March 7, 2008
        /s/ Justin W. ShiremanJustin W. ShiremanVice President, Finance and Chief Financial Officer(principal financial officer)








---
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title: Pre-Cambrianrocks of Gunnison River, Colorado**
 
Report | Plate
 
SuDoc Number:I 19.3:777
Item Number:0620 (online)
CGP systemNumber: 000959871
 
August 6, 2018
To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:36:42 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Allen Walker

Katy, TX 77493
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

<S>                                            <C>
<PERIOD-TYPE>                                  3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   MAR-31-2000
<EXCHANGE-RATE>                                1
<CASH>                                         4,037,652
<SECURITIES>                                   0
<RECEIVABLES>                                  6,404,888
<ALLOWANCES>                                   1,476,087
<INVENTORY>                                    247,564
<CURRENT-ASSETS>                               10,169,300
<PP&E>                                         38,831,518
<DEPRECIATION>                                 19,943,378
<TOTAL-ASSETS>                                 29,414,133
<CURRENT-LIABILITIES>                          5,665,868
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       7,720,193
<OTHER-SE>                                     15,127,802
<TOTAL-LIABILITY-AND-EQUITY>                   29,414,133
<SALES>                                        9,245,739
<TOTAL-REVENUES>                               9,312,656
<CGS>                                          6,290,543
<TOTAL-COSTS>                                  6,290,543
<OTHER-EXPENSES>                               1,149,565
<LOSS-PROVISION>                               104,350
<INTEREST-EXPENSE>                             344,999
<INCOME-PRETAX>                                1,527,549
<INCOME-TAX>                                   76,400
<INCOME-CONTINUING>                            1,451,149
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   1,451,149
<EPS-BASIC>                                    0.19
<EPS-DILUTED>                                  0.18



</TABLE>
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title: Preliminaryreport on the McKittrick-Sunset oil region, Kern and San Luis Obispo counties,California**
 
Report | Plates: OneTwoThreeFour
 
SuDoc Number:I 19.3:406
Item Number:0620 (online)
CGP systemNumber: 000958770
 
July 31, 2018
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders.                    

*Date:*                         January 10, 2024.                    

*Time:*                         9:45 a.m. to 5:45 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Marisa Srivareerat, Ph.D., Scientific Review Officer, Scientific Review Branch, Office of Extramural Policy, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 435-1258,                         *marisa.srivareerat@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: September 28, 2023.

Tyeshia M. Roberson-Curtis,

Program Analyst,  Office of Federal Advisory Committee Policy.

[FR Doc. 2023-21815 Filed 10-2-23; 8:45 am]

BILLING CODE 4140-01-P
1.
    
    I have reviewed this quarterly report on Form 10-Q of Monro Muffler Brake, Inc.;
 2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;
 4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
     5.
    
    The registrants other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions):
    /s/ Robert G. Gross

Robert G. GrossChief Executive Officer and Chairman of the Board
No. 58727.

protests 229329-K (B), etc. (New York).

#### Garay & Co., Inc., et al. *v.*United States,

Opinion by

Mollison, J.

The protests were dismissed.
#### In the Matter of the Claim of Dorothy E. Kloss, Respondent. Greater Saratoga Corporation, Appellant; John E. Sweeney, as Commissioner of Labor, Respondent.

[633 NYS2d 82]

—Appeal from a decision of the Unemployment Insurance Appeal Board, filed July 22, 1994, which ruled that claimant was entitled to receive unemployment insurance benefits.

Claimant, a massage therapist, worked at a health spa operated by Greater Saratoga Corporation (hereinafter GSC). She was found by the Board to be an employee of GSC and, therefore, entitled to receive unemployment insurance benefits. GSC argues that claimant was an independent contractor and that the Board’s finding to the contrary is not supported by substantial evidence. We disagree. The evidence established that GSC, among other things, provided the rooms, equipment and supplies necessary for claimant to perform her services, scheduled claimant’s appointments, assigned clients to claimant and set the fee for claimant’s services. In view of this, the Board could properly conclude that claimant was not an independent contractor. Moreover, upon our review of the record, we also find substantial evidence supporting the Board’s conclusion that claimant did not engage in misconduct justifying her termination.

Cardona, P. J., Mercure, White, Yesawich Jr. and Peters, JJ., concur. Ordered that the decision is affirmed, without costs.
[Federal Register Volume 88, Number 192 (Thursday, October 5, 2023)]
[Notices]
[Page 69115]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22154]


========================================================================
Notices
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains documents other than rules 
or proposed rules that are applicable to the public. Notices of hearings 
and investigations, committee meetings, agency decisions and rulings, 
delegations of authority, filing of petitions and applications and agency 
statements of organization and functions are examples of documents 
appearing in this section.

========================================================================


Federal Register / Vol. 88, No. 192 / Thursday, October 5, 2023 / 
Notices

[[Page 69115]]



UNITED STATES AFRICAN DEVELOPMENT FOUNDATION


Public Quarterly Meeting of the Board of Directors

AGENCY: United States African Development Foundation.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. African Development Foundation (USADF) will hold its 
quarterly meeting of the Board of Directors to discuss the agency's 
programs and administration. This meeting will occur at the USADF 
office.

DATES: The meeting date is Wednesday, November 8, 2023, 9 a.m. to 12 
noon.

ADDRESSES: The meeting location is USADF, 1400 I St. NW, Suite 1000, 
Washington, DC 20005.

FOR FURTHER INFORMATION CONTACT: Kerline Perry, (202) 233-8805.
    Authority: Public Law 96-533 (22 U.S.C. 290h).

    Dated: September 29, 2023.
Wendy Carver,
Business Manager.
[FR Doc. 2023-22154 Filed 10-4-23; 8:45 am]
BILLING CODE 6117-01-P
Exhibit 31.2

**CERTIFICATION**

I, Jay Lutsky, Principal Financial Officer, certify that:

1.         I have reviewed this periodic report on Form 10-K of Xian Resources, Ltd.;

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.         I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally  accepted accounting principles;

(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.         I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.